Published in Virology on October 10, 1998
Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice. PLoS Pathog (2005) 3.41
Luciferase imaging of a neurotropic viral infection in intact animals. J Virol (2003) 1.83
Multiple host barriers restrict poliovirus trafficking in mice. PLoS Pathog (2008) 1.65
Retrograde axonal transport: a major transmission route of enterovirus 71 in mice. J Virol (2007) 1.61
Establishment of a poliovirus oral infection system in human poliovirus receptor-expressing transgenic mice that are deficient in alpha/beta interferon receptor. J Virol (2007) 1.40
A hitchhiker's guide to the nervous system: the complex journey of viruses and toxins. Nat Rev Microbiol (2010) 1.39
Bottleneck-mediated quasispecies restriction during spread of an RNA virus from inoculation site to brain. Proc Natl Acad Sci U S A (2006) 1.32
Receptor (CD155)-dependent endocytosis of poliovirus and retrograde axonal transport of the endosome. J Virol (2004) 1.20
A nonpolio enterovirus with respiratory tropism causes poliomyelitis in intercellular adhesion molecule 1 transgenic mice. Proc Natl Acad Sci U S A (2004) 1.06
Limited trafficking of a neurotropic virus through inefficient retrograde axonal transport and the type I interferon response. PLoS Pathog (2010) 1.06
The reovirus sigma1s protein is a determinant of hematogenous but not neural virus dissemination in mice. J Virol (2011) 0.99
Making it to the synapse: measles virus spread in and among neurons. Curr Top Microbiol Immunol (2009) 0.96
Epidemics to eradication: the modern history of poliomyelitis. Virol J (2007) 0.96
Innate host barriers to viral trafficking and population diversity: lessons learned from poliovirus. Adv Virus Res (2010) 0.96
Receptor-dependent and -independent axonal retrograde transport of poliovirus in motor neurons. J Virol (2009) 0.96
The toll-like receptor 3-mediated antiviral response is important for protection against poliovirus infection in poliovirus receptor transgenic mice. J Virol (2011) 0.95
The GDVII strain of Theiler's virus spreads via axonal transport. J Virol (1999) 0.88
Distribution of Kakugo virus and its effects on the gene expression profile in the brain of the worker honeybee Apis mellifera L. J Virol (2009) 0.87
West Nile virus preferentially transports along motor neuron axons after sciatic nerve injection of hamsters. J Neurovirol (2009) 0.85
Poliovirus trafficking toward central nervous system via human poliovirus receptor-dependent and -independent pathway. Front Microbiol (2012) 0.83
Comparison of three neurotropic viruses reveals differences in viral dissemination to the central nervous system. Virology (2015) 0.82
Mechanisms controlling virulence thresholds of mixed viral populations. J Virol (2011) 0.81
Isolation and molecular characterization of a poliovirus type 1 mutant that replicates in the spinal cords of mice. J Virol (1999) 0.79
Injection of the sciatic nerve with TMEV: a new model for peripheral nerve demyelination. Virology (2006) 0.79
Dynamic viral dissemination in mice infected with yellow fever virus strain 17D. J Virol (2013) 0.78
Transferrin Receptor 1 Facilitates Poliovirus Permeation of Mouse Brain Capillary Endothelial Cells. J Biol Chem (2015) 0.77
Polio, still lurking in the shadows. J Neurosci (2013) 0.75
Spectrum of disease outcomes in mice infected with YFV-17D. J Gen Virol (2015) 0.75
Molecular aspects of poliovirus pathogenesis. Proc Jpn Acad Ser B Phys Biol Sci (2007) 0.75
Internal ribosome entry site within hepatitis C virus RNA. J Virol (1992) 9.14
A highly sensitive method to assay FK-506 levels in plasma. Transplant Proc (1987) 8.45
Complete nucleotide sequences of all three poliovirus serotype genomes. Implication for genetic relationship, gene function and antigenic determinants. J Mol Biol (1984) 8.06
A protein covalently linked to poliovirus genome RNA. Proc Natl Acad Sci U S A (1977) 7.92
The 5' end of poliovirus mRNA is not capped with m7G(5')ppp(5')Np. Proc Natl Acad Sci U S A (1976) 7.26
Complete nucleotide sequence of the attenuated poliovirus Sabin 1 strain genome. Proc Natl Acad Sci U S A (1982) 6.09
The location of the polio genome protein in viral RNAs and its implication for RNA synthesis. Nature (1977) 5.61
Prediction of acute left main coronary artery obstruction by 12-lead electrocardiography. ST segment elevation in lead aVR with less ST segment elevation in lead V(1). J Am Coll Cardiol (2001) 4.81
O4-(5'-uridylyl)tyrosine is the bond between the genome-linked protein and the RNA of poliovirus. Proc Natl Acad Sci U S A (1978) 4.68
The 5'-terminal structures of poliovirion RNA and poliovirus mRNA differ only in the genome-linked protein VPg. Proc Natl Acad Sci U S A (1977) 3.97
Construction of viable deletion and insertion mutants of the Sabin strain of type 1 poliovirus: function of the 5' noncoding sequence in viral replication. J Virol (1987) 3.79
Sequence of 3,687 nucleotides from the 3' end of Sendai virus genome RNA and the predicted amino acid sequences of viral NP, P and C proteins. Nucleic Acids Res (1983) 3.62
Nectin/PRR: an immunoglobulin-like cell adhesion molecule recruited to cadherin-based adherens junctions through interaction with Afadin, a PDZ domain-containing protein. J Cell Biol (1999) 3.47
The poliovirus receptor protein is produced both as membrane-bound and secreted forms. EMBO J (1990) 3.31
Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype. J Virol (1989) 2.98
N-linked oligosaccharides are not involved in the function of a cell-cell binding glycoprotein E-cadherin. Cell Struct Funct (1986) 2.90
Transgenic mice susceptible to poliovirus. Proc Natl Acad Sci U S A (1991) 2.87
Regulation of yAP-1 nuclear localization in response to oxidative stress. EMBO J (1997) 2.84
Two human homologues of Saccharomyces cerevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor. Nucleic Acids Res (1994) 2.81
Primary structure of poliovirus defective-interfering particle genomes and possible generation mechanisms of the particles. J Mol Biol (1986) 2.63
Determination of the complete nucleotide sequence of the Sendai virus genome RNA and the predicted amino acid sequences of the F, HN and L proteins. Nucleic Acids Res (1986) 2.60
Cloned infectious complementary DNA of the poliovirus Sabin 1 genome: biochemical and biological properties of the recovered virus. Gene (1984) 2.55
Complete nucleotide sequence of the genome of coxsackievirus B1. Virology (1987) 2.49
Pharmacokinetics of FK 506: preclinical and clinical studies. Transplant Proc (1990) 2.48
Translation of the genetic message. VII. Role of initiation factors in formation of the chain initiation complex with Escherichia coli ribosomes. Arch Biochem Biophys (1968) 2.46
Three-step method for ultrasound-guided central vein catheterization. Br J Anaesth (2012) 2.35
In vitro phenotypic markers of a poliovirus recombinant constructed from infectious cDNA clones of the neurovirulent Mahoney strain and the attenuated Sabin 1 strain. J Virol (1985) 2.26
Construction of less neurovirulent polioviruses by introducing deletions into the 5' noncoding sequence of the genome. J Virol (1989) 2.19
Antigenic variation and resistance to neutralization in poliovirus type 1. Science (1985) 2.19
Analysis of RNA synthesis of type 1 poliovirus by using an in vitro molecular genetic approach. J Virol (1987) 2.14
In vitro construction of poliovirus defective interfering particles. J Virol (1989) 2.10
Poliovirus type 1/type 3 antigenic hybrid virus constructed in vitro elicits type 1 and type 3 neutralizing antibodies in rabbits and monkeys. Proc Natl Acad Sci U S A (1988) 2.07
The genome of poliovirus is an exceptional eukaryotic mRNA. Prog Nucleic Acid Res Mol Biol (1976) 1.99
The genome-linked protein of picornaviruses. IV. Difference in the VPg's of encephalomyocarditis virus and poliovirus as evidence that the genome-linked proteins are virus-coded. Virology (1978) 1.89
Defective interfering particles of poliovirus: mapping of the deletion and evidence that the deletions in the genomes of DI(1), (2) and (3) are located in the same region. J Mol Biol (1979) 1.87
Dual stem loops within the poliovirus internal ribosomal entry site control neurovirulence. J Virol (1999) 1.86
Regulation of the yeast Yap1p nuclear export signal is mediated by redox signal-induced reversible disulfide bond formation. Mol Cell Biol (2001) 1.79
Transformation-defective mutants of Rous sarcoma virus with longer sizes of genome RNA and their highly frequent occurrences. J Virol (1979) 1.78
Functional domains of the poliovirus receptor. Proc Natl Acad Sci U S A (1991) 1.77
A new cis-acting element for RNA replication within the 5' noncoding region of poliovirus type 1 RNA. J Virol (1995) 1.70
Sequence studies of poliovirus RNA. IV. Nucleotide sequence complexities of poliovirus type 1, type 2 and two type 1 defective interfering particles RNAs, and fingerprint of the poliovirus type 3 genome. J Gen Virol (1979) 1.68
Determination of functional domains in polypyrimidine-tract-binding protein. Biochem J (1998) 1.63
Specific interaction of polypyrimidine tract-binding protein with the extreme 3'-terminal structure of the hepatitis C virus genome, the 3'X. J Virol (1997) 1.61
An infectious cDNA clone of the poliovirus Sabin strain could be used as a stable repository and inoculum for the oral polio live vaccine. Virology (1986) 1.61
Mouse homolog of poliovirus receptor-related gene 2 product, mPRR2, mediates homophilic cell aggregation. Exp Cell Res (1997) 1.60
Interaction of poliovirus with its purified receptor and conformational alteration in the virion. J Virol (1998) 1.59
A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain. J Virol (1988) 1.58
Participation of presenilin 2 in apoptosis: enhanced basal activity conferred by an Alzheimer mutation. Science (1996) 1.56
Genetic variation occurring on the genome of an in vitro insertion mutant of poliovirus type 1. J Virol (1989) 1.54
Nucleotide sequences important for translation initiation of enterovirus RNA. J Virol (1991) 1.53
Adhesion of single application bonding systems to bovine enamel and dentin. Oper Dent (2002) 1.47
Amino acid residues on human poliovirus receptor involved in interaction with poliovirus. J Biol Chem (1994) 1.47
Chordoid meningioma in a child. Case report. J Neurosurg (1998) 1.43
Crm1 (XpoI) dependent nuclear export of the budding yeast transcription factor yAP-1 is sensitive to oxidative stress. Genes Cells (1998) 1.43
Pharmacological profile of FR139317, a novel, potent endothelin ETA receptor antagonist. J Pharmacol Exp Ther (1993) 1.42
Pretransplant pharmacodynamic analysis of immunosuppressive agents using CFSE-based T-cell proliferation assay. Clin Pharmacol Ther (2009) 1.42
Genetic analysis of internal ribosomal entry site on hepatitis C virus RNA: implication for involvement of the highly ordered structure and cell type-specific transacting factors. Virology (1997) 1.40
A second group of hepatitis C viruses. Virus Genes (1991) 1.39
Malignant tumor and eosinophils. I. Prognostic significance in gastric cancer. Cancer (1986) 1.38
Translation of the genetic message. VI. The role of ribosomal subunits in binding of formylmethionyl-tRNA and its reaction with puromycin. Proc Natl Acad Sci U S A (1967) 1.36
Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor. Virology (1997) 1.36
Isolation and characterization of defective-interfering particles of poliovirus Sabin 1 strain. Virology (1985) 1.35
Purification and properties of initiation factor F3. Nature (1970) 1.35
Intracellular redistribution of truncated La protein produced by poliovirus 3Cpro-mediated cleavage. J Virol (1999) 1.33
Nucleotide sequence of the gene encoding the serotype-specific antigen of human (Wa) rotavirus: comparison with the homologous genes from simian SA11 and UK bovine rotaviruses. J Virol (1984) 1.32
Treatment of congenital dislocation of the hip by the Pavlik harness. Mechanism of reduction and usage. J Bone Joint Surg Am (1983) 1.24
Strong inclination toward transition mutation in nucleotide substitutions by poliovirus replicase. J Mol Biol (1989) 1.23
Comparative sequence analysis of the 5'terminal noncoding regions of poliovirus vaccine strain Sabin 1, Sabin 2, and Sabin 3 genomes. Virology (1981) 1.23
Primary human immunodeficiency virus type 1 viremia and central nervous system invasion in a novel hu-PBL-immunodeficient mouse strain. J Virol (1997) 1.23
Significant prolongation of disease-free period gained by oral polysaccharide K (PSK) administration after curative surgical operation of colorectal cancer. Cancer Immunol Immunother (1990) 1.23
Restriction map of double-stranded DNA copy synthesized from poliovirus Sabin 1 RNA. J Biochem (1982) 1.18
Antigenicities of Group I and II hepatitis C virus polypeptides--molecular basis of diagnosis. Virology (1993) 1.17
Requirement of the familial Alzheimer's disease gene PS2 for apoptosis. Opposing effect of ALG-3. J Biol Chem (1996) 1.17
Nucleotide sequence of a Sendai virus genome region covering the entire M gene and the 3' proximal 1013 nucleotides of the F gene. Nucleic Acids Res (1984) 1.16
Nucleotide sequence of human rotavirus genome segment 10, an RNA encoding a glycosylated virus protein. J Virol (1984) 1.16
Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage. Proc Natl Acad Sci U S A (1998) 1.15
Down-regulation of translation driven by hepatitis C virus internal ribosomal entry site by the 3' untranslated region of RNA. Arch Virol (2001) 1.15
Host range phenotype induced by mutations in the internal ribosomal entry site of poliovirus RNA. J Virol (1997) 1.15
Dietary modulation of the progression of nephropathy in aging rats: an evaluation of the importance of protein. Am J Clin Nutr (1989) 1.15
Initiation of protein synthesis in Escherichia coli. II. Role of the initiation factors in polypeptide synthesis. Cold Spring Harb Symp Quant Biol (1969) 1.14
Localisation of apoptosis and expression of apoptosis related proteins in the synovium of patients with rheumatoid arthritis. Ann Rheum Dis (1996) 1.14
Cyclosporin A-induced suppression of ongoing IgE antibody formation in the mouse. Int Arch Allergy Appl Immunol (1986) 1.13
Occupational lifting is associated with hip osteoarthritis: a Japanese case-control study. J Rheumatol (2000) 1.12
Transplacental transmission of BK virus in human. Jpn J Microbiol (1975) 1.12
Neuroradiological characteristics of ecchordosis physaliphora. Case report and review of the literature. J Neurosurg (1998) 1.11
Simultaneous induction of an HDL receptor protein (SR-BI) and the selective uptake of HDL-cholesteryl esters in a physiologically relevant steroidogenic cell model. J Lipid Res (1998) 1.11
A second gene for the African green monkey poliovirus receptor that has no putative N-glycosylation site in the functional N-terminal immunoglobulin-like domain. J Virol (1992) 1.11
Characterization of three different transgenic mouse lines that carry human poliovirus receptor gene--influence of the transgene expression on pathogenesis. Arch Virol (1994) 1.09
Neuroprotective actions of FK506 in experimental stroke: in vivo evidence against an antiexcitotoxic mechanism. J Neurosci (1997) 1.09
Interaction of poliovirus with its receptor affords a high level of infectivity to the virion in poliovirus infections mediated by the Fc receptor. J Virol (1999) 1.09
Non-invasive visualization of sperm mitochondria behavior in transgenic mice with introduced green fluorescent protein (GFP). FEBS Lett (2001) 1.08
Effect of transforming growth factor-beta on the insulin-like growth factor-I autocrine/paracrine axis in cultured rat articular chondrocytes. Exp Cell Res (1994) 1.07
Association of the Sendai virus C protein with nucleocapsids. Arch Virol (1990) 1.05
Choroid plexus papilloma in the posterior third ventricle: case report. Neurosurgery (1997) 1.04